Clinical Trial Update: A Randomized Double Blind Comparison of Atosiban in Patients With RIF Undergoing IVF Treatment [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 randomized, double-blind study evaluating atosiban for repeated implantation failure in IVF patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Repeated Implantation Failure

Drugs mentioned

• Tractocile (atosiban)

Snippet

Sponsor: Shanghai First Maternity and Infant Hospital | Conditions: Repeated Implantation Failure | Phase 1 | Status: UNKNOWN